Ken Fisher Fisher Asset Management
AUM
$252B
1-Year Return
19.67%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
AUM
$252B
AUM Growth
+$20.9B
(+9%)
Holding
1,093
Top Buys
| 1 | +$696M | |
| 2 | +$424M | |
| 3 | +$402M | |
| 4 |
SAP
SAP
|
+$354M |
| 5 |
Spotify
SPOT
|
+$353M |
Top Sells
| 1 | +$1.91B | |
| 2 | +$1.3B | |
| 3 | +$1.04B | |
| 4 |
Eli Lilly
LLY
|
+$886M |
| 5 |
JPMorgan Chase
JPM
|
+$868M |
Sector Composition
| 1 | Technology | 25.47% |
| 2 | Financials | 18.4% |
| 3 | Industrials | 9.35% |
| 4 | Healthcare | 9.18% |
| 5 | Communication Services | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
HSBC
HSBC
$229B
| $1.04B | 0.41% |
17,043,371
+1,430,797
|
|
||
77
Banco Santander
SAN
$149B
| $976M | 0.39% |
117,592,077
-10,751,133
|
|
||
78
iShares National Muni Bond ETF
MUB
$40.1B
| $931M | 0.37% |
8,914,935
+2,679,139
|
|
||
79
Illinois Tool Works
ITW
$71.3B
| $889M | 0.35% |
3,595,146
+80,527
|
|
||
80
Trane Technologies
TT
$93.2B
| $874M | 0.35% |
1,998,440
-5,115
|
|
||
81
Vanguard S&P 500 ETF
VOO
$755B
| $864M | 0.34% |
1,521,821
-9,306
|
|
||
82
Novartis
NVS
$250B
| $862M | 0.34% |
7,121,414
+358,282
|
|
||
83
Danaher
DHR
$147B
| $857M | 0.34% |
4,340,636
-294,492
|
|
||
84
Boston Scientific
BSX
$141B
| $828M | 0.33% |
7,705,384
+939,834
|
|
||
85
CSX Corp
CSX
$66.3B
| $825M | 0.33% |
25,272,260
+188,363
|
|
||
86
Invesco QQQ Trust
QQQ
$382B
| $799M | 0.32% |
1,448,522
-68,582
|
|
||
87
Novo Nordisk
NVO
$255B
| $759M | 0.3% |
11,000,916
-870,320
|
|
||
88
Royal Bank of Canada
RY
$204B
| $753M | 0.3% |
5,723,581
+5,289,330
|
|
||
89
Deutsche Bank
DB
$68B
| $746M | 0.3% |
25,471,401
+6,605,750
|
|
||
90
AB InBev
BUD
$116B
| $733M | 0.29% |
10,663,933
+454,621
|
|
||
91
Emerson Electric
EMR
$72.1B
| $692M | 0.27% |
5,193,448
+1,561,600
|
|
||
92
Banco Bilbao Vizcaya Argentaria
BBVA
$106B
| $637M | 0.25% |
41,422,112
-2,179,615
|
|
||
93
Sanofi
SNY
$119B
| $635M | 0.25% |
13,135,366
-430,963
|
|
||
94
Lloyds Banking Group
LYG
$66.4B
| $633M | 0.25% |
148,828,623
+16,705,846
|
|
||
95
Alibaba
BABA
$387B
| $597M | 0.24% |
5,267,441
+390,883
|
|
||
96
iShares Global Healthcare ETF
IXJ
$3.96B
| $594M | 0.24% |
6,903,794
-390,064
|
|
||
97
Ingersoll Rand
IR
$30.2B
| $575M | 0.23% |
6,913,924
+38,999
|
|
||
98
Crown Castle
CCI
$41.8B
| $550M | 0.22% |
5,349,349
+90,165
|
|
||
99
NatWest
NWG
$58.4B
| $531M | 0.21% |
37,531,392
+4,355,850
|
|
||
100
Vanguard FTSE Developed Markets ETF
VEA
$176B
| $529M | 0.21% |
9,282,597
+1,070,605
|
|